BRD2 and cancer: Although we cannot exclude the possibility that the higher proportion of noncoding RNAs could at least in part reflect the different cellular composition of the tumor and NAT samples, it is well documented that noncoding RNAs are frequently deregulated in cancer (60), and specifically in colon cancer (61).